ID   MAP2_HUMAN              Reviewed;         478 AA.
AC   P50579; B2RDI8; B4DUX5; G3XA91; Q8NB11;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   22-JUL-2015, entry version 157.
DE   RecName: Full=Methionine aminopeptidase 2 {ECO:0000255|HAMAP-Rule:MF_03175};
DE            Short=MAP 2 {ECO:0000255|HAMAP-Rule:MF_03175};
DE            Short=MetAP 2 {ECO:0000255|HAMAP-Rule:MF_03175};
DE            EC=3.4.11.18 {ECO:0000255|HAMAP-Rule:MF_03175};
DE   AltName: Full=Initiation factor 2-associated 67 kDa glycoprotein {ECO:0000255|HAMAP-Rule:MF_03175};
DE            Short=p67 {ECO:0000255|HAMAP-Rule:MF_03175};
DE            Short=p67eIF2 {ECO:0000255|HAMAP-Rule:MF_03175};
DE   AltName: Full=Peptidase M {ECO:0000255|HAMAP-Rule:MF_03175};
GN   Name=METAP2 {ECO:0000255|HAMAP-Rule:MF_03175};
GN   Synonyms=MNPEP, P67EIF2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=7644482; DOI=10.1073/pnas.92.17.7714;
RA   Arfin S.M., Kendall R.L., Hall L., Weaver L.H., Stewart A.E.,
RA   Matthews B.W., Bradshaw R.A.;
RT   "Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent
RT   enzymes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:7714-7718(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=7873610; DOI=10.1016/0167-4781(94)00227-T;
RA   Li X., Chang Y.;
RT   "Molecular cloning of a human complementary DNA encoding an initiation
RT   factor 2-associated protein (p67).";
RL   Biochim. Biophys. Acta 1260:333-336(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Heart, Placenta, and Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION IN EIF2S1 PROTECTION, AND GLYCOSYLATION.
RX   PubMed=2511207;
RA   Datta B., Ray M.K., Chakrabarti D., Wylie D.E., Gupta N.K.;
RT   "Glycosylation of eukaryotic peptide chain initiation factor 2 (eIF-
RT   2)-associated 67-kDa polypeptide (p67) and its possible role in the
RT   inhibition of eIF-2 kinase-catalyzed phosphorylation of the eIF-2
RT   alpha-subunit.";
RL   J. Biol. Chem. 264:20620-20624(1989).
RN   [8]
RP   COFACTOR.
RX   PubMed=12718546; DOI=10.1021/bi020670c;
RA   Wang J., Sheppard G.S., Lou P., Kawai M., Park C., Egan D.A.,
RA   Schneider A., Bouska J., Lesniewski R., Henkin J.;
RT   "Physiologically relevant metal cofactor for methionine
RT   aminopeptidase-2 is manganese.";
RL   Biochemistry 42:5035-5042(2003).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45; SER-60; SER-63 AND
RP   SER-74, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=20521764; DOI=10.1021/bi1005464;
RA   Xiao Q., Zhang F., Nacev B.A., Liu J.O., Pei D.;
RT   "Protein N-terminal processing: substrate specificity of Escherichia
RT   coli and human methionine aminopeptidases.";
RL   Biochemistry 49:5588-5599(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45 AND SER-74, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21537465; DOI=10.4331/wjbc.v1.i10.313;
RA   Wu S.;
RT   "Localization and function of a eukaryotic-initiation-factor-2-
RT   associated 67-kDa glycoprotein.";
RL   World J. Biol. Chem. 1:313-320(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) IN COMPLEX WITH FUMAGILLIN, AND
RP   COFACTOR.
RX   PubMed=9812898; DOI=10.1126/science.282.5392.1324;
RA   Liu S., Widom J., Kemp C.W., Crews C.M., Clardy J.;
RT   "Structure of human methionine aminopeptidase-2 complexed with
RT   fumagillin.";
RL   Science 282:1324-1327(1998).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) IN COMPLEX WITH COBALT IONS AND
RP   BENGAMIDE, AND FUNCTION.
RX   PubMed=14534293; DOI=10.1074/jbc.M309039200;
RA   Towbin H., Bair K.W., DeCaprio J.A., Eck M.J., Kim S., Kinder F.R.,
RA   Morollo A., Mueller D.R., Schindler P., Song H.K., van Oostrum J.,
RA   Versace R.W., Voshol H., Wood J., Zabludoff S., Phillips P.E.;
RT   "Proteomics-based target identification: bengamides as a new class of
RT   methionine aminopeptidase inhibitors.";
RL   J. Biol. Chem. 278:52964-52971(2003).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 110-478 IN COMPLEX WITH
RP   INHIBITOR A-357300.
RX   PubMed=15012983; DOI=10.1016/j.bmcl.2003.12.031;
RA   Sheppard G.S., Wang J., Kawai M., BaMaung N.Y., Craig R.A.,
RA   Erickson S.A., Lynch L., Patel J., Yang F., Searle X.B., Lou P.,
RA   Park C., Kim K.H., Henkin J., Lesniewski R.;
RT   "3-amino-2-hydroxyamides and related compounds as inhibitors of
RT   methionine aminopeptidase-2.";
RL   Bioorg. Med. Chem. Lett. 14:865-868(2004).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 110-478 IN COMPLEX WITH
RP   4-ARYL-1,2,3-TRIAZOLE AND COBALT IONS.
RX   PubMed=16134930; DOI=10.1021/jm050408c;
RA   Kallander L.S., Lu Q., Chen W., Tomaszek T., Yang G., Tew D.,
RA   Meek T.D., Hofmann G.A., Schulz-Pritchard C.K., Smith W.W.,
RA   Janson C.A., Ryan M.D., Zhang G.-F., Johanson K.O., Kirkpatrick R.B.,
RA   Ho T.F., Fisher P.W., Mattern M.R., Johnson R.K., Hansbury M.J.,
RA   Winkler J.D., Ward K.W., Veber D.F., Thompson S.K.;
RT   "4-aryl-1,2,3-triazole: a novel template for a reversible methionine
RT   aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in
RT   vivo.";
RL   J. Med. Chem. 48:5644-5647(2005).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEXES WITH ZINC IONS AND
RP   METHIONINE, AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=16540317; DOI=10.1016/j.bmcl.2006.02.047;
RA   Nonato M.C., Widom J., Clardy J.;
RT   "Human methionine aminopeptidase type 2 in complex with L- and D-
RT   methionine.";
RL   Bioorg. Med. Chem. Lett. 16:2580-2583(2006).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 110-478 IN COMPLEX WITH
RP   MANGANESE AND INHIBITOR.
RX   PubMed=17350258; DOI=10.1016/j.bmcl.2007.02.062;
RA   Wang G.T., Mantei R.A., Kawai M., Tedrow J.S., Barnes D.M., Wang J.,
RA   Zhang Q., Lou P., Garcia L.A., Bouska J., Yates M., Park C.,
RA   Judge R.A., Lesniewski R., Sheppard G.S., Bell R.L.;
RT   "Lead optimization of methionine aminopeptidase-2 (MetAP2) inhibitors
RT   containing sulfonamides of 5,6-disubstituted anthranilic acids.";
RL   Bioorg. Med. Chem. Lett. 17:2817-2822(2007).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 110-478 IN COMPLEX WITH
RP   COBALT IONS AND INHIBITOR, COFACTOR, AND FUNCTION.
RX   PubMed=17636946; DOI=10.1021/jm061182w;
RA   Marino J.P. Jr., Fisher P.W., Hofmann G.A., Kirkpatrick R.B.,
RA   Janson C.A., Johnson R.K., Ma C., Mattern M., Meek T.D., Ryan M.D.,
RA   Schulz C., Smith W.W., Tew D.G., Tomazek T.A. Jr., Veber D.F.,
RA   Xiong W.C., Yamamoto Y., Yamashita K., Yang G., Thompson S.K.;
RT   "Highly potent inhibitors of methionine aminopeptidase-2 based on a
RT   1,2,4-triazole pharmacophore.";
RL   J. Med. Chem. 50:3777-3785(2007).
CC   -!- FUNCTION: Cotranslationally removes the N-terminal methionine from
CC       nascent proteins. The N-terminal methionine is often cleaved when
CC       the second residue in the primary sequence is small and uncharged
CC       (Met-Ala-, Cys, Gly, Pro, Ser, Thr, or Val). The catalytic
CC       activity of human METAP2 toward Met-Val peptides is consistently
CC       two orders of magnitude higher than that of METAP1, suggesting
CC       that it is responsible for processing proteins containing N-
CC       terminal Met-Val and Met-Thr sequences in vivo.
CC   -!- FUNCTION: Protects eukaryotic initiation factor EIF2S1 from
CC       translation-inhibiting phosphorylation by inhibitory kinases such
CC       as EIF2AK2/PKR and EIF2AK1/HCR. Plays a critical role in the
CC       regulation of protein synthesis.
CC   -!- CATALYTIC ACTIVITY: Release of N-terminal amino acids,
CC       preferentially methionine, from peptides and arylamides.
CC       {ECO:0000255|HAMAP-Rule:MF_03175, ECO:0000269|PubMed:20521764}.
CC   -!- COFACTOR:
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03175,
CC         ECO:0000269|PubMed:12718546, ECO:0000269|PubMed:17636946,
CC         ECO:0000269|PubMed:9812898};
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03175,
CC         ECO:0000269|PubMed:12718546, ECO:0000269|PubMed:17636946,
CC         ECO:0000269|PubMed:9812898};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03175,
CC         ECO:0000269|PubMed:12718546, ECO:0000269|PubMed:17636946,
CC         ECO:0000269|PubMed:9812898};
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03175,
CC         ECO:0000269|PubMed:12718546, ECO:0000269|PubMed:17636946,
CC         ECO:0000269|PubMed:9812898};
CC       Note=Binds 2 divalent metal cations per subunit. Has a high-
CC       affinity and a low affinity metal-binding site. The true nature of
CC       the physiological cofactor is under debate. The enzyme is active
CC       with cobalt, zinc, manganese or divalent iron ions. Most likely,
CC       methionine aminopeptidases function as mononuclear Fe(2+)-
CC       metalloproteases under physiological conditions, and the
CC       catalytically relevant metal-binding site has been assigned to the
CC       histidine-containing high-affinity site. Also manganese has been
CC       proposed to be the physiological cofactor for human METAP2.
CC       {ECO:0000255|HAMAP-Rule:MF_03175, ECO:0000269|PubMed:12718546,
CC       ECO:0000269|PubMed:17636946, ECO:0000269|PubMed:9812898};
CC   -!- SUBUNIT: Interacts strongly with the eIF-2 gamma-subunit EIF2S3
CC       (By similarity). Binds EIF2S1 at low magnesium concentrations.
CC       {ECO:0000250, ECO:0000269|PubMed:14534293,
CC       ECO:0000269|PubMed:15012983, ECO:0000269|PubMed:16134930,
CC       ECO:0000269|PubMed:17350258, ECO:0000269|PubMed:17636946,
CC       ECO:0000269|PubMed:9812898}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03175,
CC       ECO:0000269|PubMed:21537465}. Note=About 30% of expressed METAP2
CC       associates with polysomes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P50579-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P50579-2; Sequence=VSP_055467, VSP_055468;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P50579-3; Sequence=VSP_057353;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Contains approximately 12 O-linked N-acetylglucosamine
CC       (GlcNAc) residues. O-glycosylation is required for EIF2S1 binding.
CC       {ECO:0000255|HAMAP-Rule:MF_03175, ECO:0000269|PubMed:2511207}.
CC   -!- SIMILARITY: Belongs to the peptidase M24A family. Methionine
CC       aminopeptidase eukaryotic type 2 subfamily. {ECO:0000255|HAMAP-
CC       Rule:MF_03175}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/METAP2ID46053ch12q22.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U29607; AAA82930.1; -; mRNA.
DR   EMBL; U13261; AAC63402.1; -; mRNA.
DR   EMBL; AK091730; BAC03733.1; -; mRNA.
DR   EMBL; AK300836; BAG62487.1; -; mRNA.
DR   EMBL; AK315559; BAG37935.1; -; mRNA.
DR   EMBL; AC018475; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97537.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW97538.1; -; Genomic_DNA.
DR   EMBL; BC013782; AAH13782.1; -; mRNA.
DR   CCDS; CCDS9052.1; -. [P50579-1]
DR   PIR; S52112; DPHUM2.
DR   RefSeq; NP_006829.1; NM_006838.3. [P50579-1]
DR   UniGene; Hs.444986; -.
DR   PDB; 1B59; X-ray; 1.80 A; A=109-478.
DR   PDB; 1B6A; X-ray; 1.60 A; A=1-478.
DR   PDB; 1BN5; X-ray; 1.80 A; A=1-478.
DR   PDB; 1BOA; X-ray; 1.80 A; A=1-478.
DR   PDB; 1KQ0; X-ray; 2.00 A; A=1-478.
DR   PDB; 1KQ9; X-ray; 1.90 A; A=1-478.
DR   PDB; 1QZY; X-ray; 1.60 A; A=1-478.
DR   PDB; 1R58; X-ray; 1.90 A; A=110-478.
DR   PDB; 1R5G; X-ray; 2.00 A; A=110-478.
DR   PDB; 1R5H; X-ray; 2.40 A; A=110-478.
DR   PDB; 1YW7; X-ray; 1.85 A; A=110-478.
DR   PDB; 1YW8; X-ray; 2.65 A; A=110-478.
DR   PDB; 1YW9; X-ray; 1.64 A; A=110-478.
DR   PDB; 2ADU; X-ray; 1.90 A; A=110-478.
DR   PDB; 2EA2; X-ray; 2.50 A; A=110-478.
DR   PDB; 2EA4; X-ray; 2.35 A; A=110-478.
DR   PDB; 2GA2; X-ray; 1.95 A; A=110-478.
DR   PDB; 2OAZ; X-ray; 1.90 A; A=110-478.
DR   PDBsum; 1B59; -.
DR   PDBsum; 1B6A; -.
DR   PDBsum; 1BN5; -.
DR   PDBsum; 1BOA; -.
DR   PDBsum; 1KQ0; -.
DR   PDBsum; 1KQ9; -.
DR   PDBsum; 1QZY; -.
DR   PDBsum; 1R58; -.
DR   PDBsum; 1R5G; -.
DR   PDBsum; 1R5H; -.
DR   PDBsum; 1YW7; -.
DR   PDBsum; 1YW8; -.
DR   PDBsum; 1YW9; -.
DR   PDBsum; 2ADU; -.
DR   PDBsum; 2EA2; -.
DR   PDBsum; 2EA4; -.
DR   PDBsum; 2GA2; -.
DR   PDBsum; 2OAZ; -.
DR   ProteinModelPortal; P50579; -.
DR   SMR; P50579; 110-478.
DR   BioGrid; 116184; 24.
DR   IntAct; P50579; 2.
DR   MINT; MINT-2803706; -.
DR   STRING; 9606.ENSP00000325312; -.
DR   BindingDB; P50579; -.
DR   ChEMBL; CHEMBL3922; -.
DR   DrugBank; DB00134; L-Methionine.
DR   DrugBank; DB01422; Nitroxoline.
DR   GuidetoPHARMACOLOGY; 1573; -.
DR   MEROPS; M24.002; -.
DR   PhosphoSite; P50579; -.
DR   BioMuta; METAP2; -.
DR   DMDM; 1703273; -.
DR   REPRODUCTION-2DPAGE; IPI00033036; -.
DR   MaxQB; P50579; -.
DR   PaxDb; P50579; -.
DR   PeptideAtlas; P50579; -.
DR   PRIDE; P50579; -.
DR   DNASU; 10988; -.
DR   Ensembl; ENST00000261220; ENSP00000261220; ENSG00000111142. [P50579-2]
DR   Ensembl; ENST00000323666; ENSP00000325312; ENSG00000111142.
DR   Ensembl; ENST00000546753; ENSP00000448169; ENSG00000111142. [P50579-3]
DR   GeneID; 10988; -.
DR   KEGG; hsa:10988; -.
DR   UCSC; uc001tec.3; human. [P50579-1]
DR   UCSC; uc001tef.3; human.
DR   UCSC; uc010suv.2; human.
DR   CTD; 10988; -.
DR   GeneCards; GC12P095800; -.
DR   HGNC; HGNC:16672; METAP2.
DR   HPA; CAB013025; -.
DR   HPA; HPA019095; -.
DR   MIM; 601870; gene.
DR   neXtProt; NX_P50579; -.
DR   PharmGKB; PA30765; -.
DR   eggNOG; COG0024; -.
DR   GeneTree; ENSGT00530000063220; -.
DR   HOGENOM; HOG000226278; -.
DR   HOVERGEN; HBG050495; -.
DR   InParanoid; P50579; -.
DR   KO; K01265; -.
DR   OMA; WCRRYLE; -.
DR   PhylomeDB; P50579; -.
DR   TreeFam; TF300426; -.
DR   BRENDA; 3.4.11.18; 2681.
DR   Reactome; REACT_163919; Inactivation, recovery and regulation of the phototransduction cascade.
DR   ChiTaRS; METAP2; human.
DR   EvolutionaryTrace; P50579; -.
DR   GeneWiki; METAP2; -.
DR   GenomeRNAi; 10988; -.
DR   NextBio; 35475297; -.
DR   PRO; PR:P50579; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; P50579; -.
DR   CleanEx; HS_METAP2; -.
DR   ExpressionAtlas; P50579; baseline and differential.
DR   Genevisible; P50579; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:HGNC.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0004177; F:aminopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-HAMAP.
DR   GO; GO:0070006; F:metalloaminopeptidase activity; IEA:UniProtKB-HAMAP.
DR   GO; GO:0008235; F:metalloexopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB.
DR   GO; GO:0031365; P:N-terminal protein amino acid modification; IDA:HGNC.
DR   GO; GO:0018206; P:peptidyl-methionine modification; IDA:HGNC.
DR   GO; GO:0007603; P:phototransduction, visible light; TAS:Reactome.
DR   GO; GO:0070084; P:protein initiator methionine removal; IEA:UniProtKB-HAMAP.
DR   GO; GO:0016485; P:protein processing; IDA:HGNC.
DR   GO; GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 3.90.230.10; -; 2.
DR   HAMAP; MF_03175; MetAP_2_euk; 1.
DR   InterPro; IPR001714; Pept_M24_MAP.
DR   InterPro; IPR000994; Pept_M24_structural-domain.
DR   InterPro; IPR002468; Pept_M24A_MAP2.
DR   InterPro; IPR018349; Pept_M24A_MAP2_BS.
DR   InterPro; IPR011991; WHTH_DNA-bd_dom.
DR   Pfam; PF00557; Peptidase_M24; 1.
DR   PRINTS; PR00599; MAPEPTIDASE.
DR   SUPFAM; SSF55920; SSF55920; 2.
DR   TIGRFAMs; TIGR00501; met_pdase_II; 1.
DR   PROSITE; PS01202; MAP_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Aminopeptidase;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; Glycoprotein;
KW   Hydrolase; Metal-binding; Phosphoprotein; Protease;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:19413330}.
FT   CHAIN         2    478       Methionine aminopeptidase 2.
FT                                /FTId=PRO_0000148982.
FT   COMPBIAS     41     46       Poly-Lys.
FT   COMPBIAS     98    106       Poly-Lys.
FT   METAL       251    251       Divalent metal cation 1.
FT   METAL       262    262       Divalent metal cation 1.
FT   METAL       262    262       Divalent metal cation 2; catalytic.
FT   METAL       331    331       Divalent metal cation 2; catalytic; via
FT                                tele nitrogen.
FT   METAL       364    364       Divalent metal cation 2; catalytic.
FT   METAL       459    459       Divalent metal cation 1.
FT   METAL       459    459       Divalent metal cation 2; catalytic.
FT   BINDING     231    231       Substrate.
FT   BINDING     339    339       Substrate.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000269|PubMed:19413330}.
FT   MOD_RES      45     45       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:20068231}.
FT   MOD_RES      60     60       Phosphoserine; alternate.
FT                                {ECO:0000269|PubMed:18669648}.
FT   MOD_RES      63     63       Phosphoserine; alternate.
FT                                {ECO:0000269|PubMed:18669648}.
FT   MOD_RES      74     74       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:20068231}.
FT   CARBOHYD     60     60       O-linked (GlcNAc); alternate.
FT                                {ECO:0000250}.
FT   CARBOHYD     63     63       O-linked (GlcNAc); alternate.
FT                                {ECO:0000250}.
FT   VAR_SEQ      50     50       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055467.
FT   VAR_SEQ      87    109       DGDGDGDGATGKKKKKKKKKRGP -> A (in isoform
FT                                2). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055468.
FT   VAR_SEQ     109    132       PKVQTDPPSVPICDLYPNGVFPKG -> R (in isoform
FT                                3). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057353.
FT   CONFLICT    434    434       N -> D (in Ref. 3; BAC03733).
FT                                {ECO:0000305}.
FT   HELIX       120    123       {ECO:0000244|PDB:1B6A}.
FT   STRAND      133    135       {ECO:0000244|PDB:1B6A}.
FT   STRAND      141    143       {ECO:0000244|PDB:1R58}.
FT   HELIX       149    151       {ECO:0000244|PDB:1YW9}.
FT   HELIX       154    161       {ECO:0000244|PDB:1B6A}.
FT   HELIX       163    186       {ECO:0000244|PDB:1B6A}.
FT   HELIX       193    208       {ECO:0000244|PDB:1B6A}.
FT   TURN        212    214       {ECO:0000244|PDB:1B6A}.
FT   STRAND      215    225       {ECO:0000244|PDB:1B6A}.
FT   STRAND      228    230       {ECO:0000244|PDB:1B6A}.
FT   STRAND      248    256       {ECO:0000244|PDB:1B6A}.
FT   STRAND      259    267       {ECO:0000244|PDB:1B6A}.
FT   HELIX       271    273       {ECO:0000244|PDB:1B6A}.
FT   HELIX       274    290       {ECO:0000244|PDB:1B6A}.
FT   HELIX       297    309       {ECO:0000244|PDB:1B6A}.
FT   STRAND      312    315       {ECO:0000244|PDB:1B6A}.
FT   STRAND      318    321       {ECO:0000244|PDB:1B6A}.
FT   STRAND      329    334       {ECO:0000244|PDB:1B6A}.
FT   STRAND      337    339       {ECO:0000244|PDB:1QZY}.
FT   STRAND      343    349       {ECO:0000244|PDB:1B6A}.
FT   STRAND      360    370       {ECO:0000244|PDB:1B6A}.
FT   STRAND      382    385       {ECO:0000244|PDB:1B6A}.
FT   HELIX       397    409       {ECO:0000244|PDB:1B6A}.
FT   TURN        410    412       {ECO:0000244|PDB:1B6A}.
FT   HELIX       417    422       {ECO:0000244|PDB:1B6A}.
FT   HELIX       429    437       {ECO:0000244|PDB:1B6A}.
FT   STRAND      440    444       {ECO:0000244|PDB:1B6A}.
FT   STRAND      455    464       {ECO:0000244|PDB:1B6A}.
FT   STRAND      469    471       {ECO:0000244|PDB:1B6A}.
SQ   SEQUENCE   478 AA;  52892 MW;  5788E4BB83E48F9A CRC64;
     MAGVEEVAAS GSHLNGDLDP DDREEGAAST AEEAAKKKRR KKKKSKGPSA AGEQEPDKES
     GASVDEVARQ LERSALEDKE RDEDDEDGDG DGDGATGKKK KKKKKKRGPK VQTDPPSVPI
     CDLYPNGVFP KGQECEYPPT QDGRTAAWRT TSEEKKALDQ ASEEIWNDFR EAAEAHRQVR
     KYVMSWIKPG MTMIEICEKL EDCSRKLIKE NGLNAGLAFP TGCSLNNCAA HYTPNAGDTT
     VLQYDDICKI DFGTHISGRI IDCAFTVTFN PKYDTLLKAV KDATNTGIKC AGIDVRLCDV
     GEAIQEVMES YEVEIDGKTY QVKPIRNLNG HSIGQYRIHA GKTVPIVKGG EATRMEEGEV
     YAIETFGSTG KGVVHDDMEC SHYMKNFDVG HVPIRLPRTK HLLNVINENF GTLAFCRRWL
     DRLGESKYLM ALKNLCDLGI VDPYPPLCDI KGSYTAQFEH TILLRPTCKE VVSRGDDY
//
